Vertex Pharmaceuticals (VRTX) market cap

Market cap today
$135.44B

Vertex Pharmaceuticals (VRTX) has a market cap of $135.44B. At the end of fiscal 2025 (December 31, 2025) its market cap was $116.97B. That is 12.6% higher than the $103.86B of fiscal 2024. Today's figure is 15.8% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$135.44B
Market cap, fiscal 2025
$116.97B
Change on fiscal 2024
+12.6%
Growth, 5 years
+13.4% a year
Growth, 10 years
+14.4% a year
Highest on record
$116.97Bfiscal 2025
Lowest on record
$4.27Bfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vertex Pharmaceuticals market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 13.4% a year; over ten years the rate was 14.4% a year. Across the 18 fiscal year-ends on record (2008–2025), the highest was $116.97B in fiscal 2025 and the lowest $4.27B in fiscal 2008.

History · 18 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Vertex Pharmaceuticals market cap, year by year

Vertex Pharmaceuticals (VRTX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$135.44B—$534.20—
2025$116.97B 12.6% up$453.36258.00M
2024$103.86B 2.0% down$402.70257.90M
2023$105.99B 41.7% up$406.89260.50M
2022$74.82B 31.1% up$288.78259.10M
2021$57.07B 8.3% down$219.60259.90M
2020$62.25B 9.1% up$236.34263.40M
2019$57.08B 32.9% up$218.95260.70M
2018$42.95B 13.2% up$165.71259.19M
2017$37.95B 110.5% up$149.86253.23M
2016$18.03B 40.6% down$73.67244.69M
2015$30.36B 8.6% up$125.83241.31M
2014$27.95B 67.3% up$118.80235.31M
2013$16.71B 85.3% up$74.30224.91M
2012$9.02B 30.1% up$41.90215.26M
2011$6.93B 1.2% down$33.21208.81M
2010$7.02B 5.4% down$35.03200.40M
2009$7.42B 73.9% up$42.85173.26M
2008$4.27B—$30.38140.56M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Vertex Pharmaceuticals and comparable companies
CompanyMarket cap
Pfizer PFE$162.27B
Danaher DHR$158.84B
Intuitive Surgical ISRG$149.24B
Vertex Pharmaceuticals VRTX$135.44B
Medtronic MDT$130.88B
Bristol-Myers Squibb BMY$125.40B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals market cap: questions and answers

What is Vertex Pharmaceuticals's market cap?

Vertex Pharmaceuticals (VRTX) has a market cap of $135.44B. At the end of fiscal 2025 (December 31, 2025) its market cap was $116.97B. That is 12.6% higher than the $103.86B of fiscal 2024.

What is the growth rate of Vertex Pharmaceuticals's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 13.4% a year; over ten years the rate was 14.4% a year.

What are the highest and lowest market cap figures on record for Vertex Pharmaceuticals?

Across the 18 fiscal year-ends on record (2008–2025), the highest was $116.97B in fiscal 2025 and the lowest $4.27B in fiscal 2008.

How is Vertex Pharmaceuticals's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.